Validation of the ICSD-2 Criteria for CSF Hypocretin-1 Measurements in the Diagnosis of Narcolepsy in the Danish Population
Authors:
Open Access
- 1 February 2010
- journal article
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 33 (2) , 169-176
Abstract
The International Classification of Sleep Disorders (ICSD-2) criteria for low CSF hypocretin-1 levels (CSF hcrt-1) still need validation as a diagnostic tool for narcolepsy in different populations because inter-assay variability and different definitions of hypocretin deficiency complicate direct comparisons of study results. Interviews, polysomnography, multiple sleep latency test, HLA-typing, and CSF hcrt-1 measurements in Danish patients with narcolepsy with cataplexy (NC) and narcolepsy without cataplexy (NwC), CSF hcrt-1 measurements in other hypersomnias, neurological and normal controls. Comparisons of hypocretin deficiency and frequency of HLA-DQB1*0602-positivity in the Danish and eligible NC and NwC populations (included via MEDLINE search), by (re)calculation of study results using the ICSD-2 criterion for low CSF hcrt-1 (<30% of normal mean). In Danes, low CSF hcrt-1 was present in 40/46 NC, 3/14 NwC and 0/106 controls (P < 0.0001). Thirty-nine of 41 NC and 4/13 NwC patients were HLA-DQB1 *0602-positive (P < 0.01). Hypocretin-deficient NC patients had higher frequency of cataplexy, shorter mean sleep latency, more sleep onset REM periods (P < 0.05) and more awakenings (NS) than did NC patients with normal CSF hcrt-1. Across populations, low CSF hcrt-1 and HLA-DQB1*0602-positivity characterized the majority of NC (80% to 100%, P = 0.53; 80% to 100%, P = 0.11) but a minority of NwC patients (11% to 29%, P = 0.75; 29% to 89%, P = 0.043). The study provides evidence that hypocretin deficiency causes a more severe NC phenotype. The ICSD-2 criterion for low CSF hcrt-1 (<30% of normal mean) is valid for diagnosing NC, but not NwC. HLA-typing should precede CSF hcrt-1 measurements because hypocretin deficiency is rare in HLA-DQB1*0602-negative patients.Keywords
This publication has 38 references indexed in Scilit:
- Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritisMultiple Sclerosis Journal, 2008
- Cataplexy features in childhood narcolepsyMovement Disorders, 2008
- Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative diseaseBrain, 2007
- HLA-DQB1 Allele and Hypocretin in Korean Narcoleptics with CataplexyJournal of Korean Medical Science, 2007
- Follow‐up of four narcolepsy patients treated with intravenous immunoglobulinsAnnals of Neurology, 2006
- Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adultsBrain, 2006
- Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexyJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Normal CSF Hypocretin-1 (Orexin A) Levels in Dementia with Lewy Bodies Associated with Excessive Daytime SleepinessEuropean Neurology, 2004
- CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditionsJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Undetectable Levels of CSF Hypocretin-1 (Orexin-A) in Two Prepubertal Boys with NarcolepsyNeuropediatrics, 2002